Development of atherosclerosis in osteopontin transgenic mice
Article Properties
-
DOI (url)
-
Publication Date2002/04/01
-
Journal
-
Indian UGC (journal)
-
Citations52
-
Satoru Chiba
-
H. Okamoto
-
Shigeyuki Kon
-
Chiemi Kimura
-
Masaaki Murakami
-
Manabu Inobe
-
Yutaka Matsui
-
Takeshi Sugawara
-
Toshihiro Shimizu
-
Toshimitsu Uede
-
Akira Kitabatake
Cite
Chiba, Satoru, et al. “Development of Atherosclerosis in Osteopontin Transgenic Mice”. Heart and Vessels, vol. 16, no. 3, 2002, pp. 111-7, https://doi.org/10.1007/s003800200005.
Chiba, S., Okamoto, H., Kon, S., Kimura, C., Murakami, M., Inobe, M., Matsui, Y., Sugawara, T., Shimizu, T., Uede, T., & Kitabatake, A. (2002). Development of atherosclerosis in osteopontin transgenic mice. Heart and Vessels, 16(3), 111-117. https://doi.org/10.1007/s003800200005
Chiba, Satoru, H. Okamoto, Shigeyuki Kon, Chiemi Kimura, Masaaki Murakami, Manabu Inobe, Yutaka Matsui, et al. “Development of Atherosclerosis in Osteopontin Transgenic Mice”. Heart and Vessels 16, no. 3 (2002): 111-17. https://doi.org/10.1007/s003800200005.
Chiba S, Okamoto H, Kon S, Kimura C, Murakami M, Inobe M, et al. Development of atherosclerosis in osteopontin transgenic mice. Heart and Vessels. 2002;16(3):111-7.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the circulatory (Cardiovascular) system
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the respiratory system
Medicine
Medicine (General)
You May Also Like
- New Criteria for `Obesity Disease' in Japan
- Adiponectin as a Biomarker of the Metabolic Syndrome
- Impending Epidemic Future Projection of Heart Failure in Japan to the Year 2055
- Adipokines: A link between obesity and cardiovascular disease
- Coronary artery spasm—Clinical features, diagnosis, pathogenesis, and treatment
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Matricellular proteins in atherosclerosis development | Matrix Biology |
| 4 | 2023 |
The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)—A Narrative Review | Biomedicines |
| 2023 | |
The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods | Molecules |
| 5 | 2023 |
Lactoferrin, Osteopontin and Lactoferrin–Osteopontin Complex: A Critical Look on Their Role in Perinatal Period and Cardiometabolic Disorders | Nutrients |
| 3 | 2023 |
| Levels of miR-130b-5p in peripheral blood are associated with severity of coronary artery disease | Molecular Biology Reports |
| 8 | 2021 |
Citations Analysis
The category
Medicine: Medicine (General) 28
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Plasma osteopontin levels are associated with the presence and extent of coronary artery disease and was published in 2003. The most recent citation comes from a 2023 study titled The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)—A Narrative Review. This article reached its peak citation in 2023, with 4 citations. It has been cited in 36 different journals, 13% of which are open access. Among related journals, the Arteriosclerosis, Thrombosis, and Vascular Biology cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.